1. Naik B, Karunakar P, Jayadev M, Marshal VR. Role of Platelet rich fibrin in wound healing: A critical review. J conservative dent: JCD. 2013;16(4):284-293.

2. Brown CH, 3rd, Weisberg RJ, Natelson EA, Alfrey CP, Jr. Glanzmann’s thrombasthenia; assessment of the response to platelet transfusions. Transfusion. 1975;15(2):124-131.

3. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applicationsin oral and maxillofacialsurgery. J oral maxillofacsurg: official journal of the American Association of Oral and Maxillofacial Surgeons. 1997;55(11):1294-1299.

4. Weibrich G, Kleis WK, Hafner G, Hitzler WE, Wagner W. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003;14(3):357-362.

5. Leitner GC, Gruber R, Neumuller J, Wagner A, Kloimstein P, Hocker P, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox sanguinis. 2006;91(2):135-139.

6. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529-535.

7. Weibrich G, Kleis WK, Buch R, Hitzler WE, Hafner G. The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Clin Oral Implants Res. 2003;14(2):233-239.

8. Dohan Ehrenfest DM, Rasmusson L,Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyteand platelet-rich fibrin (L-PRF). Trends in biotech. 2009;27(3):158-167.

9. Clausen C, Hermund NU, Donatsky O, Nielsen H, Osther K. Homologous activated platelets stimulate differentiation and proliferation of primary human bone cells. Cells, tissues, organs. 2006;184(2):68-75.

10. UggeriJ,Belletti S, Guizzardi S, PoliT,Cantarelli S, Scandroglio R, et al. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts. J Periodont. 2007;78(10):1985-1991.

11. Krasna M, Domanovic D, Tomsic A, Svajger U, Jeras M. Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 2007;16(3):105-110.

12. Anitua E,Andia I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. Journal of orthopaedic research : Official Public Ortho Res Soc. 2005;23(2):281-286.

13. Cenni E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodont. 2005;76(3):323- 328.

14. Slapnicka J, Fassmann A, Strasak L, Augustin P, Vanek J. Effects of activated and nonactivated platelet-rich plasma on proliferation of human osteoblasts in vitro. Journal of oral and maxillofacial surgery : Official J American Assoc Oral Maxillofac Surg. 2008;66(2):297-301.

15. Arenas MD, Rebollo P, Malek T, Moledous A, Gil MT, Alvarez-Ude F, et al. A comparative study of 2 new phosphate binders(sevelamer and lanthanum carbonate) in routine clinical practice. J Neph 2010;23(6):683-692.

16. Dori F, Nikolidakis D, Huszar T, Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. J Clin Periodont. 2008;35(1):44- 50.

17. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006;101(3):e56-60.

18. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006;101(3):e37-44.

19. Preeja C, Arun S. Platelet-rich fibrin: Its role in periodontal regeneration. Saudi J Dent Res. 2014;5(2):117-122.

20. Michael Toffler NT, Dan Holtzclaw, Marco Del Corso, David Dohan Ehrenfest. Introducing Choukroun’s Platelet Rich Fibrin (PRF) to the Reconstructive Surgery Milieu. J Implant Advanced Clin Dent. 2009;1(6):21-32.

21. Nelson R. Pinto AP, Paula Jimenex, Marco Del Corso, Byung-Soo Kang, Hom-Lay Wang, Marc Quirynen, David M. Dohan Ehrenfest. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors and fibrin architecture of a Leukocyte- and Platelet-Rich Fibrin (L-PRF) clot and membrane. Part 2: macroscopic, photonic microscopy and Scanning Electron Microscopy analysis of 4 kinds of L-PRF clots and membranes. Periodontology, Oral Surgery, Esthetic&Implant Dentistry Open. 2014;2(2):155-166.

22. Lundquist R, Dziegiel MH, Agren MS. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2008;16(3):356-363.

23. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblastsin vitro. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2009;108(5):707- 713.

24. Wu CL, Lee SS, Tsai CH, Lu KH, Zhao JH, Chang YC. Platelet-rich fibrin increases cell attachment, proliferation and collagen-related protein expression of human osteoblasts. Australian Dent J. 2012;57(2):207-212.

25. Douglas TE, Gassling V, Declercq HA, Purcz N, Pamula E, Haugen HJ, et al. Enzymatically induced mineralization of platelet-rich fibrin. J Biomedl Materials Res PartA. 2012;100(5):1335- 1346.

26. Chang IC, Tsai CH, Chang YC. Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Materials Res Part A. 2010;95(1):327-332.

27. Clipet F, Tricot S, Alno N, Massot M, Solhi H, CathelineauG, et al.InvitroeffectsofChoukroun’s platelet-rich fibrin conditioned medium on 3 different cell lines implicated in dental implantology. Implant Dent. 2012;21(1):51-56.

28. Gassling V, Douglas T, Warnke PH,Acil Y, Wiltfang J, Becker ST. Platelet-rich fibrin membranes asscaffoldsfor periosteal tissue engineering. Clin Oral Implants Res. 2010;21(5):543-549.

29. Huang FM, Yang SF, Zhao JH, Chang YC. Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. J Endo. 2010;36(10):1628-1632.

30. Srisurang S, Kantheera B, Narit L, Prisana P. Socket preservation using platelet-rich fibrin in conjunction with epithelialized palatal free graft in minipigs. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2014;26(2):108-117.

31. SimonpieriA, Del Corso M, Sammartino G, Dohan Ehrenfest DM.The relevance ofChoukroun’s platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implantsurgery, prosthodontics, and survival. Implant dentistry. 2009;18(3):220- 229.

32. van HinsberghVW,CollenA, Koolwijk P.Role of fibrin matrix in angiogenesis.Annals of the New York Academy of Sciences. 2001;936:426-437.

33. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006;101(3):299-303.

34. Jankovic S,Aleksic Z, Klokkevold P, Lekovic V, Dimitrijevic B, Kenney EB, et al. Use of platelet-rich fibrin membrane following treatment of gingival recession: a randomized clinical trial. The International journal of periodontics & restorative dentistry. 2012;32(2):e41-50.

35. Del Corso M, Mazor Z, Rutkowski JL, Dohan Ehrenfest DM. The use of leukocyte- and platelet-rich fibrin during immediate postextractive implantation and loading for the esthetic replacement of a fractured maxillary central incisor. J Oral Implant. 2012;38(2):181-187.

36. Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun’s platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodont. 2009;80(12):2056-2064.

37. Shivashankar VY, Johns DA, Vidyanath S, Kumar MR. Platelet Rich Fibrin in the revitalization of tooth with necrotic pulp and open apex. J Conservative Dent : JCD. 2012;15(4):395-398.

38. Hiremath H, Saikalyan S, Kulkarni SS, Hiremath V. Second-generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report. Int Endod J. 2012;45(1):105-112.

39. Keswani D, Pandey RK, Ansari A, Gupta S. Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial. J Endod. 2014;40(5):599-605.